Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of B cells treated with recombinant CD52-Fc

ABSTRACT: RNA-seq of B cells treated with recombinant CD52-Fc

PROVIDER: PRJNA684946 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13249167.fastq.gz	Fastqsanger.gz
	SRR13249168.fastq.gz	Fastqsanger.gz
	SRR13249169.fastq.gz	Fastqsanger.gz
	SRR13249170.fastq.gz	Fastqsanger.gz
	SRR13249171.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

RNA-seq of B cells treated with recombinant CD52-Fc

Project description:CD52 is a 12 amino acid glycoprotein that is widely expressed on lymphocytes. In T cells, the soluble form of CD52 has been shown to inhibit TCR function by binding Siglec-10. In Monocytes, soluble CD52 has been shown to inhibit TLR signaling and induces apoptosis at high concentrations. To assess the impact of CD52 on B cell function, we left B cells either untreated or exposed to recombinant CD52-Fc for 6 hours prior to lysis and bulk RNA-sequencing. Gene expression analysis revealed that soluble CD52 induced downregulation of immunoglobulin and B cell receptor related genes such as CD19 and CD22. Therefore, soluble CD52 appears to have a suppressive role on B cell function.

2020-12-14 | GSE163123 | GEO

CD52 and OXPHOS - potential targets in ibrutinib treated mantle cell lymphoma

Project description:CD52 and OXPHOS - potential targets in ibrutinib treated mantle cell lymphoma

| PRJNA886758 | ENA

Mapping of nascent RNA in MLL2 F/F and FC/FC MEF cells

Project description:Global Run-On has been performed in MLL2 F/F and FC/FC MEF cells. The aim of the experiment is to test how the lack of MLL2 affects nascent RNA transcription. Four samples were analyzed - 2 independent replicates. The experiments were performed using immortalized mouse embryonic fibroblasts (MEF) in which both MLL2 alleles were targeted by the loxp system (F/F cells). Tamoxifen treatment of the F/F cells for 24 hours results in the excision of both MLL2 alleles (FC/FC cells).

2016-04-13 | E-GEOD-73126 | biostudies-arrayexpress

Human osteoblast treated with recombinant TGF-beta

Project description:Global expression profile of human osteoblast treated with recombinant TGF-beta compared to human osteoblast treated with growth media alone

2010-09-30 | GSE17843 | GEO

RNA-seq of mouse primary keratinocytes treated with recombinant IL-33

Project description:Mouse primary keratinocytes were treated with recombinant IL-33 to elucidate the effect of IL-33 signaling on keratinocytes

2021-02-22 | GSE145963 | GEO

Mapping of nascent RNA in MLL2 F/F and FC/FC MEF cells

Project description:Global Run-On has been performed in MLL2 F/F and FC/FC MEF cells. The aim of the experiment is to test how the lack of MLL2 affects nascent RNA transcription.

2016-04-13 | GSE73126 | GEO

Identify the master regulator of ILT3.Fc induced perturbation in Jurkat cells

Project description:Generate gene expression profile of ILT3.Fc treated Jurkat cells

2020-10-25 | GSE106147 | GEO

Geitlerinema sp. FC II strain:FC II

Project description:Geitlerinema sp. FC II strain:FC II Genome sequencing and assembly

| PRJNA399071 | ENA

RNA-seq of mouse primary keratinocytes treated with recombinant IL-33

Project description:RNA-seq of mouse primary keratinocytes treated with recombinant IL-33

| PRJNA608891 | ENA

Insulin-stimulated glucose uptake in recombinant MMP12 treated 3T3-L1 cells

Project description:Insulin-stimulated glucose uptake in recombinant MMP12 treated 3T3-L1 cells